A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria

Tropical Medicine and International Health

Volumn 1, Issue 1, 1996, Pages 124-132

  Muller O ^a,c   Van Hensbroek, M Boele ^a   Jaffar, S ^a   Drakeley, C ^a   Okorie, C ^b   Joof, D ^b   Pinder, M ^a   Greenwood, B ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b Ministry of Health   (Gambia)

^c Financial Systems Development Section   (Germany)

Author keywords

chloroquine resistance; malaria; The Gambia

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DRUG EFFICACY; FEMALE; FOLLOW UP; GAMBIA; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; ORAL DRUG ADMINISTRATION; RURAL AREA; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 9244225096     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1996.d01-13.x     Document Type: Article

References (26)

1. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R & Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
2. Brewster DR & Greenwood BM (1993) Seasonal variation of paediatric diseases in The Gambia, West Africa. Annals of Tropical Paediatrics 13, 133-146.
3. CDC (1985) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium faldparum. M. M. W. R. 34, 185-194.
4. Deloron P, Le Bras J & Ramanamirija JA (1984) Amodiaquine and chloroquine efficacy against Plasmodium falciparum in Madagascar. Lancet i, 1303-1304.
5. Fadat G, Le Bras J, Hengy C, Louis JP, Gimou MM & Verdier F (1991) Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon. Lancet 338, 1091.
6. Greenwood BM, Bradley AK, Greenwood AM et al. (1987a) Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Transactions of the Royal Society for Tropical Medicine and Hygiene 81, 478-486.
7. Greenwood BM (1987b) Asymptomatic malaria infections -do they matrer? Parasitology Today 3, 206-214.
8. Greenwood BM & Armstrong JRM (1991) Comparison of two simple methods for determining malaria parasite density. Transactions of the Royal Society for Tropical Medicine and Hygiene 85, 186-188.
9. Hatton CSR, Peto TEA, Bunch C et al. (1986) Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet i, 411-414.
10. Irare SGM, Lemenge MMM & Mhina JIK (1991) Faldparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of resistance in Dodoma, Tanzania. Tropical and Geographical Medicine and Hygiene 43, 252-256.
11. Kamugisha J, Kipp W & Burnham G (1994) In vivo sensitivity of Plasmodium faldparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in Western Uganda. Tropical and Geographical Medicine 46, 364-365.
12. Keuter M, van Eijk A, Hoogstrate M et al. (1990) Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega district, Kenya. British Medical Journal 301, 466-470.
13. Keuter M, Sanders J, Ronday M et al. (1992) Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and to pyrimethamine-sulfadoxine with quinine in western Kenya. Tropical and (Geographical Medicine 44, 1-8.
14. Menon A, Snow RW, Otoo L & Greenwood BM (1987) Decline in sensitivity of Plasmodium falciparum to chloroquine in The Gambia. Lancet ii, 1029-1030.
15. Menon A, Otoo LN, Herbage KA & Greenwood BM (1990) A national survey of the prevalence of chloroquine-resistant Plasmodium falciparum in The Gambia. Transactions of the Royal Society for Tropical Medicine and Hygiene 84, 638-640.
16. Ministry of Health, Labour and Social Welfare (1985) National Primary Healthcare Programme 1985. Banjul: Government of The Gambia 1-166.
17. Neftel KW, Woodtly W, Schmid M, Frick PG & Fehr J (1986) Amodiaquine induced agranulocytosis and liver damage. British Medical Journal 292, 721-723.
18. Nevill CG, Munafu CG, Khan B, Muller A & Gachihi G (1994) Amodiaquine not pyrimethamine sulfadoxine should replace chloroquine for the primary treatment of non-severe P. falciparum malaria in Eastern Africa. VI International Conference on Infectious Diseases 1994, Prague (abstr. 991).
19. Panton LJ, Tulloch S, Bradley AK & Greenwood BM (1985) Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine. Transactions of the Royal Society for Tropical Medicine and Hygiene 79, 484-490.
20. Pappaioanou M, Lobel HO & Campbell CC (1988) A quantitative approach to recommendations on malaria prophylaxis. Bulletin of the World Health Organization 66, 477-484.
21. Pinchepongse S, Doberstyn EB, Cullen JR, Yisunsri L, Thongsombun Y &: Thimasarn K (1981) An evaluation of five regimens for the out-patient therapy of falciparum malaria in Thailand. Bulletin of the World Health Organization 60, 907-912.
22. Spencer HC, Oloo AJ, Watkins WW, Sixsmith DG, Churchill FC & Koech DK (1984) Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on Kenya coast. Lancet i, 956-957.
23. Steffen R, Heusser R, Mächler R, et al. (1990) Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bulletin of the World Health Organization 68, 313-322.
24. Sudre P, Breman JC, McFarland D & Koplan JP (1992) Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. International Journal of Epidemiology 21, 146-154.
25. Watkins WM, Sixsmith DG, Spencer HC et al. (1984) Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum malaria infections in Kenya. Lancet i, 357-359.
26. WHO (1990) Practical Chemotherapy of Malaria. Technical Report Series 805, World Health Organization, Geneva.